1
|
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F. Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. J Crohns Colitis 2017; 11:515. [PMID: 27927719 DOI: 10.1093/ecco-jcc/jjw207] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Cláudia Camila Dias
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,CINTESIS - Center for Health Technology and Services Research, Porto, Portugal
| | - Pedro Pereira Rodrigues
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,CINTESIS - Center for Health Technology and Services Research, Porto, Portugal
| | - Rosa Coelho
- Gastroenterology Department, Hospital São João, Porto, Portugal
| | - Paula Moura Santos
- Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
| | - Samuel Fernandes
- Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
| | - Paula Lago
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Cidalina Caetano
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Ângela Rodrigues
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Francisco Portela
- Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Ana Oliveira
- Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Paula Ministro
- Gastroenterology Department, Centro Hospitalar Tondela e Viseu, Tondela e Viseu, Portugal
| | - Eugénia Cancela
- Gastroenterology Department, Centro Hospitalar Tondela e Viseu, Tondela e Viseu, Portugal
| | - Ana Isabel Vieira
- Gastroenterology Department, Hospital Garcia da Orta, Lisboa, Portugal
| | - Rita Barosa
- Gastroenterology Department, Hospital Garcia da Orta, Lisboa, Portugal
| | - José Cotter
- Gastroenterology Department, Centro Hospitalar do Alto Ave, Guimarães, Portugal
| | - Pedro Carvalho
- Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Isabelle Cremers
- Gastroenterology Department, Centro Hospitalar de Setúbal, Hospital São Bernardo, Setúbal, Portugal
| | - Daniel Trabulo
- Gastroenterology Department, Centro Hospitalar de Setúbal, Hospital São Bernardo, Setúbal, Portugal
| | - Paulo Caldeira
- Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.,Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Artur Antunes
- Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Isadora Rosa
- Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal
| | - Joana Moleiro
- Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal
| | - Paula Peixe
- Gastroenterology Department, Centro Hospitalar Lisboa Oriental Portugal, Lisboa, Portugal
| | - Rita Herculano
- Gastroenterology Department, Centro Hospitalar Lisboa Oriental Portugal, Lisboa, Portugal
| | | | - Bruno Gonçalves
- Gastroenterology Department, Hospital de Braga, Braga, Portugal
| | - Helena Tavares Sousa
- Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.,Gastroenterology Department, Portimão Unit, Centro Hospitalar do Algarve, Portimão, Portugal
| | - Luís Contente
- Gastroenterology Department, Portimão Unit, Centro Hospitalar do Algarve, Portimão, Portugal
| | - Henrique Morna
- Gastroenterology Department, Hospital Nélio Mendonça, Funchal, Portugal
| | - Susana Lopes
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal
| | - Fernando Magro
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,Institute of Pharmacology and Therapeutics Faculty of Medicine of the University of Porto, Porto, Portugal.,MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal
| | | |
Collapse
|
2
|
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F. Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. J Crohns Colitis 2017; 11:445-453. [PMID: 27683799 DOI: 10.1093/ecco-jcc/jjw171] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Accepted: 09/22/2016] [Indexed: 12/22/2022]
Abstract
INTRODUCTION The establishment of prognostic models for Crohn's disease [CD] is highly desirable, as they have the potential to guide physicians in the decision-making process concerning therapeutic choices, thus improving patients' health and quality of life. Our aim was to derive models for disabling CD and reoperation based solely on clinical/demographic data. METHODS A multicentric and retrospectively enrolled cohort of CD patients, subject to early surgery or immunosuppression, was analysed in order to build Bayesian network models and risk matrices. The final results were validated internally and with a multicentric and prospectively enrolled cohort. RESULTS The derivation cohort included a total of 489 CD patients [64% with disabling disease and 18% who needed reoperation], while the validation cohort included 129 CD patients with similar outcome proportions. The Bayesian models achieved an area under the curve of 78% for disabling disease and 86% for reoperation. Age at diagnosis, perianal disease, disease aggressiveness and early therapeutic decisions were found to be significant factors, and were used to construct user-friendly matrices depicting the probability of each outcome in patients with various combinations of these factors. The matrices exhibit good performance for the most important criteria: disabling disease positive post-test odds = 8.00 [2.72-23.44] and reoperation negative post-test odds = 0.02 [0.00-0.11]. CONCLUSIONS Clinical and demographical risk factors for disabling CD and reoperation were determined and their impact was quantified by means of risk matrices, which are applicable as bedside clinical tools that can help physicians during therapeutic decisions in early disease management.
Collapse
Affiliation(s)
- Cláudia Camila Dias
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,CINTESIS - Center for Health Technology and Services Research, Porto, Portugal
| | - Pedro Pereira Rodrigues
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,CINTESIS - Center for Health Technology and Services Research, Porto, Portugal
| | - Rosa Coelho
- Gastroenterology Department, Hospital São João, Porto, Portugal
| | - Paula Moura Santos
- Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
| | - Samuel Fernandes
- Gastroenterology Department, Faculty of Medicine, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
| | - Paula Lago
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Cidalina Caetano
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Ângela Rodrigues
- Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal
| | - Francisco Portela
- Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Ana Oliveira
- Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Paula Ministro
- Gastroenterology Department, Centro Hospitalar Tondela e Viseu, Tondela e Viseu, Portugal
| | - Eugénia Cancela
- Gastroenterology Department, Centro Hospitalar Tondela e Viseu, Tondela e Viseu, Portugal
| | - Ana Isabel Vieira
- Gastroenterology Department, Hospital Garcia da Orta, Lisboa, Portugal
| | - Rita Barosa
- Gastroenterology Department, Hospital Garcia da Orta, Lisboa, Portugal
| | - José Cotter
- Gastroenterology Department, Centro Hospitalar do Alto Ave, Guimarães, Portugal
| | - Pedro Carvalho
- Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Isabelle Cremers
- Gastroenterology Department, Centro Hospitalar de Setúbal, Hospital São Bernardo, Setúbal, Portugal
| | - Daniel Trabulo
- Gastroenterology Department, Centro Hospitalar de Setúbal, Hospital São Bernardo, Setúbal, Portugal
| | - Paulo Caldeira
- Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.,Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Artur Antunes
- Gastroenterology Department, Hospital de Faro, Faro, Portugal
| | - Isadora Rosa
- Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal
| | - Joana Moleiro
- Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal
| | - Paula Peixe
- Gastroenterology Department, Centro Hospitalar Lisboa Oriental Portugal, Lisboa, Portugal
| | - Rita Herculano
- Gastroenterology Department, Centro Hospitalar Lisboa Oriental Portugal, Lisboa, Portugal
| | | | - Bruno Gonçalves
- Gastroenterology Department, Hospital de Braga, Braga, Portugal
| | - Helena Tavares Sousa
- Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.,Gastroenterology Department, Portimão Unit, Centro Hospitalar do Algarve, Portimão, Portugal
| | - Luís Contente
- Gastroenterology Department, Portimão Unit, Centro Hospitalar do Algarve, Portimão, Portugal
| | - Henrique Morna
- Gastroenterology Department, Hospital Nélio Mendonça, Funchal, Portugal
| | - Susana Lopes
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal
| | - Fernando Magro
- Health Information and Decision Sciences Department, Faculty of Medicine of the University of Porto, Porto, Portugal.,Institute of Pharmacology and Therapeutics Faculty of Medicine of the University of Porto, Porto, Portugal.,MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal
| | | |
Collapse
|
3
|
Areia M, Alves S, Brito D, Cadime AT, Carvalho R, Saraiva S, Ferreira S, Moleiro J, Pereira AD, Carrasquinho J, Lopes L, Ramada J, Marcos-Pinto R, Pedroto I, Contente L, Eliseu L, Vieira AM, Sampaio M, Sousa HT, Almeida N, Gregório C, Portela F, Sofia C, Braga V, Baginha E, Bana e Costa T, Chagas C, Mendes LL, Magalhães-Costa P, Matos L, Gonçalves FR, Dinis-Ribeiro M. Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence country. J Gastrointestin Liver Dis 2015; 23:371-8. [PMID: 25531994 DOI: 10.15403/jgld.2014.1121.234.hrq] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
BACKGROUND AND AIMS A recent review of economic studies relating to gastric cancer revealed that authors use different tests to estimate utilities in patients with and without gastric cancer. Our aim was to determine the utilities of gastric premalignant conditions and adenocarcinoma with a single standardized health measure instrument. METHODS Cross-sectional nationwide study of patients undergoing upper endoscopy (n=1,434) using the EQ-5D-5L quality of life (QoL) questionnaire. RESULTS According to EQ-5D-5L, utilities in individuals without gastric lesions were 0.78 (95% confidence interval: 0.76-0.80), with gastric premalignant conditions 0.79 (0.77-0.81), previously treated for gastric cancer 0.77 (0.73-0.81) and with present cancer 0.68 (0.55-0.81). Self-reported QoL according to the visual analogue scale (VAS) for the same groups were 0.67 (0.66-0.69), 0.67 (0.66-0.69), 0.62 (0.59-0.65) and 0.62 (0.54-0.70) respectively. Utilities were consistently lower in women versus men (no lesions 0.71 vs. 0.78; premalignant conditions 0.70 vs. 0.82; treated for cancer 0.72 vs. 0.78 and present cancer 0.66 vs. 0.70). CONCLUSION The health-related QoL utilities of patients with premalignant conditions are similar to those without gastric diseases whereas patients with present cancer show decreased utilities. Moreover, women had consistently lower utilities than men. These results confirm that the use of a single standardized instrument such as the EQ-5D-5L for all stages of the gastric carcinogenesis cascade is feasible and that it captures differences between conditions and gender dissimilarities, being relevant information for authors pretending to conduct further cost-utility analysis.
Collapse
Affiliation(s)
- Miguel Areia
- Center for Research in Health Technologies and Information Systems, Faculty of Medicine,Porto University; Gastroenterology Dept., Portuguese Oncology Institute of Coimbra,Portugal.
| | - Susana Alves
- Gastroenterology Dept., Portuguese Oncology Institute of Coimbra, Portugal
| | - Daniel Brito
- Gastroenterology Dept., Portuguese Oncology Institute of Coimbra, Portugal
| | - Ana Teresa Cadime
- Gastroenterology Dept., Portuguese Oncology Institute of Coimbra, Portugal
| | - Rita Carvalho
- Gastroenterology Dept., Portuguese Oncology Institute of Coimbra, Portugal
| | - Sandra Saraiva
- Gastroenterology Dept., Portuguese Oncology Institute of Coimbra, Portugal
| | - Sara Ferreira
- Gastroenterology Dept., Portuguese Oncology Institute of Lisbon, Portugal
| | - Joana Moleiro
- Gastroenterology Dept., Portuguese Oncology Institute of Lisbon, Portugal
| | | | - João Carrasquinho
- Gastroenterology Dept., Santa Luzia Hospital - Viana do Castelo (Local Health Unit of Alto Minho), Portugal
| | - Luís Lopes
- Gastroenterology Dept., Santa Luzia Hospital - Viana do Castelo (Local Health Unit of Alto Minho), Portugal
| | - José Ramada
- Gastroenterology Dept., Santa Luzia Hospital - Viana do Castelo (Local Health Unit of Alto Minho), Portugal
| | - Ricardo Marcos-Pinto
- Center for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto University; Gastroenterology Dept., Santo António General Hospital, Hospital Centre of Porto; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal
| | - Isabel Pedroto
- Gastroenterology Dept., Santo António General Hospital, Hospital Centre of Porto; Institute of Biomedical Sciences Abel Salazar,University of Porto, Portugal
| | - Luís Contente
- Gastroenterology Dept., Hospital Unit of Portimão (Hospital Center of Western Algarve), Portugal
| | - Liliana Eliseu
- Gastroenterology Dept., Hospital Unit of Portimão (Hospital Center of Western Algarve), Portugal
| | - Ana Margarida Vieira
- Gastroenterology Dept., Hospital Unit of Portimão (Hospital Center of Western Algarve), Portugal
| | - Margarida Sampaio
- Gastroenterology Dept., Hospital Unit of Portimão (Hospital Center of Western Algarve), Portugal
| | - Helena Tavares Sousa
- Gastroenterology Dept., Hospital Unit of Portimão (Hospital Center of Western Algarve), Portugal
| | - Nuno Almeida
- Gastroenterology Dept., Coimbra University Hospital Center; Portugal
| | - Carlos Gregório
- Gastroenterology Dept., Coimbra University Hospital Center; Portugal
| | - Francisco Portela
- Gastroenterology Dept., Coimbra University Hospital Center; Portugal
| | - Carlos Sofia
- Gastroenterology Dept., Coimbra University Hospital Center; Portugal
| | - Vânia Braga
- Gastroenterology Dept., Portuguese Oncology Institute of Porto, Portugal
| | - Elisabete Baginha
- Gastroenterology Dept., West Lisbon Hospital Centre, Lisbon, Portugal
| | | | - Cristina Chagas
- Gastroenterology Dept., West Lisbon Hospital Centre, Lisbon, Portugal
| | - Luís Lebre Mendes
- Gastroenterology Dept., West Lisbon Hospital Centre, Lisbon, Portugal
| | | | - Leopoldo Matos
- Gastroenterology Dept., West Lisbon Hospital Centre, Lisbon, Portugal
| | - Francisco Rocha Gonçalves
- Center for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto University; Gastroenterology Dept., Portuguese Oncology Institute of Porto, Portugal
| | - Mário Dinis-Ribeiro
- Center for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto University; Gastroenterology Dept., Portuguese Oncology Institute of Porto, Portugal
| |
Collapse
|
4
|
Abstract
In the exposure of microcircuits, it is attractive to replace contact printing with projection printing to avoid direct contact between the silicon wafer and glass master. Since etched photoresists do not exhibit a gray scale, the conventional criteria of projection printing do not apply. In order to establish adequate criteria for projection printing onto photoresists, the imaging properties of diffraction-limited optics and the recording characteristics of photoresists are examined. A criterion based on edge uncertainty of lines is proposed. Other aspects of projection systems are briefly considered.
Collapse
|